FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078771 [Registered on: 30/12/2024] Trial Registered Prospectively
Last Modified On: 25/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Genetic studies on congenital cataract patients from North-India 
Scientific Title of Study   Genetic studies on some prevalent vision defects in Aligarh. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohammad Afzal 
Designation  Professor (Retd.) 
Affiliation  Aligarh Muslim University 
Address  Department of Zoology
Aligarh Muslim University, Aligarh
Aligarh
UTTAR PRADESH
202002
India 
Phone  9897839601  
Fax    
Email  afzal1235@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Aal E Fatima 
Designation  Research Scholar 
Affiliation  Aligarh Muslim University 
Address  Department of Zoology
Aligarh Muslim University, Aligarh
Aligarh
UTTAR PRADESH
202002
India 
Phone  8532851383  
Fax    
Email  aalefatima1425@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mohammad Afzal 
Designation  Professor (Retd.) 
Affiliation  Aligarh Muslim University 
Address  Department of Zoology
Aligarh Muslim University, Aligarh
Aligarh
UTTAR PRADESH
202002
India 
Phone  9897839601  
Fax    
Email  afzal1235@rediffmail.com  
 
Source of Monetary or Material Support  
Department of Zoology, Aligarh Muslim University, Aligarh, Uttar Pradesh, India, Pin-202002 
 
Primary Sponsor  
Name  University Grants Commission 
Address  Bahadur Shah Zafar Marg, New Delhi-110002. 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
UGC NonNET  Bahadur Shah Zafar Marg, New Delhi-110002. 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof Mohammad Afzal  Jawaharlal Nehru Medical College  Department of Ophthalmology,Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh
Aligarh
UTTAR PRADESH 
9897839601

afzal1235@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Jawaharlal Nehru Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H260||Infantile and juvenile cataract,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Patients diagnosed with congenital cataracts, aged 0-18 years, either unilateral or bilateral, confirmed through clinical examination. 
 
ExclusionCriteria 
Details  Patients having a history of intrauterine infection (TORCH), toxoplasmosis, others (hepatitis B, syphilis), rubella, cytomegalovirus, Herpes simplex virus; Other ocular clinical manifestations such as glaucoma, microcephaly, micro-opthalamos, uveal coloboma, and retinal disgeneration to rule out any systemic involvement
; Maternal history of steroid uses; Trauma
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The study is expected to identify novel genetic mutations and provide a better understanding of the genetic and environmental factors contributing to congenital cataracts in North India.   One Year 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary objectives include investigating familial patterns, exploring environmental interactions, & studying genetic variations across different ethnic groups.We also aim to develop genetic counseling guidelines for families at risk.  Two Years 
 
Target Sample Size   Total Sample Size="25"
Sample Size from India="25" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  15/01/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response (Others) -  NIL

  6. For how long will this data be available start date provided 15-01-2026 and end date provided 31-12-2027?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   India’s large, diverse population offers a unique opportunity to study the genetic basis of congenital cataracts. Regional, ethnic, and socioeconomic diversity may reveal population-specific mutations not seen globally. In North India, where genetic studies on congenital cataracts are scarce, identifying these mutations can aid early interventions and reduce childhood blindness. Current diagnostic approaches, relying on clinical examinations, fail to uncover genetic causes and limited access to genetic screening exacerbates the issue. This study aims to bridge this gap by improving diagnosis, treatment, and counseling. Findings will enhance genotype-phenotype understanding, inform healthcare strategies, and contribute to global genetic research on congenital cataracts. 
Close